PAP 2023: Gwen Cooper Discusses Insights from Access PAP Session Activities

A panel examines the gross-to-net bubble across various product mixes, how pricing impacts market access, and more.

A session provides considerations for manufacturers during development, rollouts, and implementation, specifically as it pertains to the HSSP perspective.

A session investigates the drivers of these shortages and ways to mitigate them.

Breakout session explores how direct-to-patient models shorten the time to diagnosis and therapy to improve patient outcomes.

The seminar focuses on US supply chain resiliency, while remaining compliant and preserving patient access.

A panel uncovers how distribution channels are aligning commercialization efforts.